Previously snubbed, pancreatic cancer gaining R&D, funding momentum
This article was originally published in Scrip
Executive Summary
As deadly, hard-to-treat diseases go, pancreatic cancer is among the worst – ranking fourth in the US as the leading cause of death, with the lowest five-year relative survival rate of all major cancers, at just 6%.